Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-18

Clinical Trial Update: Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of Bimiralisib Gel in actinic keratosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bimiralisib Gel (bimiralisib)

Snippet

Sponsor: TORQUR | Conditions: Actinic Keratosis | Phase 2 | Status: COMPLETED